EUVIMEDEUVIMED entdecken
Crossref

Recombinant vaccines against Leptospirosis

Odir A Dellagostin, André A Grassmann, Daiane D Hartwig, Samuel R Félix, Éverton F da Silva, Alan J A McBride

Human Vaccines · 2011-11 · 7 (11) · 1215-1224

DOI: 10.4161/hv.7.11.17944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Vaccines, online erschienen am 27.10.2014. Verfasst von Odir A Dellagostin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Biotecnologia, Centro de Desenvolvimento Tecnológico, Salvador, BA, Brazil. odir@ufpel.edu.br. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 122 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptospirosis is an important neglected infectious disease that occurs in urban environments, as well as in rural regions worldwide. Rodents, the principal reservoir hosts of pathogenic Leptospira spp., and other infected animals shed the bacteria in their urine. During occupational or even recreational activities, humans that come into direct contact with infected animals or with a contaminated environment, particularly water, are at risk of infection. Prevention of urban leptospirosis is largely dependent on sanitation measures that are often difficult to implement, especially in developing countries. Vaccination with inactivated whole-cell preparations (bacterins) has limited efficacy due to the wide antigenic variation of the pathogen. Intensive efforts towards developing improved recombinant vaccines are ongoing. During the last decade, many reports on the evaluation of recombinant vaccines have been published. Partial success has been obtained with some surface-exposed protein antigens. The combination of protective antigens and new adjuvants or delivery systems may result in the much-needed effective vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntigens, BacterialBacterial VaccinesCallithrixCricetinaeDisease Models, AnimalGerbillinaeGuinea PigsHumansLeptospiraLeptospirosisMesocricetusRatsVaccines, Synthetic

Substanzen

Antigens, BacterialBacterial VaccinesVaccines, Synthetic

Autor:innen und Institutionen

  • Unidade de Biotecnologia, Centro de Desenvolvimento Tecnológico, Salvador, BA, Brazil. odir@ufpel.edu.br

Zitieren

APA

Dellagostin, O. A., Grassmann, A. A., Hartwig, D. D., Félix, S. R., da Silva, É. F., & McBride, A. J. (2011). Recombinant vaccines against Leptospirosis. Human Vaccines, 7(11), 1215-1224. https://doi.org/10.4161/hv.7.11.17944

Vancouver

Dellagostin OA, Grassmann AA, Hartwig DD, Félix SR, da Silva ÉF, McBride AJ. Recombinant vaccines against Leptospirosis. Human Vaccines. 2011;7(11):1215-1224. doi:10.4161/hv.7.11.17944

BibTeX
@article{Dellagostin2011,
  author = {Dellagostin, Odir A and Grassmann, André A and Hartwig, Daiane D and Félix, Samuel R and da Silva, Éverton F and McBride, Alan J A},
  title = {Recombinant vaccines against Leptospirosis},
  journal = {Human Vaccines},
  year = {2011},
  volume = {7},
  number = {11},
  pages = {1215--1224},
  doi = {10.4161/hv.7.11.17944}
}
Kostenlos starten →